GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » E10

Ipca Laboratories (BOM:524494) E10 : ₹65.84 (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ipca Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was ₹9.780. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹65.84 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-02), Ipca Laboratories's current stock price is ₹1393.20. Ipca Laboratories's E10 for the quarter that ended in Dec. 2024 was ₹65.84. Ipca Laboratories's Shiller PE Ratio of today is 21.16.

During the past 13 years, the highest Shiller PE Ratio of Ipca Laboratories was 26.33. The lowest was 19.72. And the median was 23.02.


Ipca Laboratories E10 Historical Data

The historical data trend for Ipca Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories E10 Chart

Ipca Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ipca Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 66.83 65.84

Competitive Comparison of Ipca Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Shiller PE Ratio falls into.


;
;

Ipca Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ipca Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=9.78/158.3229*158.3229
=9.780

Current CPI (Dec. 2024) = 158.3229.

Ipca Laboratories Quarterly Data

per share eps CPI Adj_EPS
200603 4.920 45.521 17.112
200703 10.058 48.581 32.778
200803 10.826 52.407 32.706
200903 8.000 56.615 22.372
201003 16.410 65.030 39.952
201103 20.950 70.768 46.869
201203 21.970 76.889 45.239
201303 25.650 85.687 47.393
201403 37.920 91.425 65.667
201503 20.150 97.163 32.834
201603 7.380 102.518 11.397
201703 15.420 105.196 23.208
201803 18.970 109.786 27.357
201806 2.715 111.317 3.861
201809 4.691 115.142 6.450
201812 6.299 115.142 8.661
201903 3.900 118.202 5.224
201906 5.120 120.880 6.706
201909 7.640 123.175 9.820
201912 7.815 126.235 9.801
202003 3.386 124.705 4.299
202006 17.620 127.000 21.966
202009 10.555 130.118 12.843
202012 5.230 130.889 6.326
202103 6.359 131.771 7.640
202106 12.090 134.084 14.276
202109 9.860 135.847 11.491
202112 7.760 138.161 8.892
202203 5.140 138.822 5.862
202206 5.640 142.347 6.273
202209 5.670 144.661 6.205
202212 4.250 145.763 4.616
202303 3.020 146.865 3.256
202306 6.420 150.280 6.764
202309 5.720 151.492 5.978
202312 7.090 152.924 7.340
202403 2.340 153.035 2.421
202406 7.580 155.789 7.703
202409 9.050 157.882 9.075
202412 9.780 158.323 9.780

Add all the adjusted EPS together and divide 10 will get our e10.


Ipca Laboratories  (BOM:524494) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ipca Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1393.20/65.84
=21.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ipca Laboratories was 26.33. The lowest was 19.72. And the median was 23.02.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ipca Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories Headlines

No Headlines